nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

11.03.2019 | Retraction Note

Retraction Note to: SOX2 oncogenes amplified and operate to activate AKT signalling in gastric cancer and predict immunotherapy responsiveness

verfasst von: Yajun Tian, Xin Jia, Shengxiang Wang, Yongsheng Li, Peng Zhao, Da Cai, Zequan Zhou, Junmin Wang, Yi Luo, Maosheng Dong

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Excerpt

The Editor-in-Chief is retracting this article (Tian et al. 2014) due to concerns regarding peer review, authorship and originality of the article. The identities of the peer reviewers suggested by the authors could not be confirmed. Additionally, the article shows evidence of irregularities in authorship during the submission process. The authors listed in the revised and published article are different from the authors listed on the submitted manuscript. Furthermore, there appears to be substantial text overlap with a number of previously published articles (Oshima et al. 2013; Zhang et al. 2014; Kishiki et al. 2014; Roukos 2010; Liu et al. 2014). The authors have not responded to any correspondence from the editor/publisher about this retraction. …

Titel: Retraction Note to: SOX2 oncogenes amplified and operate to activate AKT signalling in gastric cancer and predict immunotherapy responsiveness
verfasst von: Yajun Tian
Xin Jia
Shengxiang Wang
Yongsheng Li
Peng Zhao
Da Cai
Zequan Zhou
Junmin Wang
Yi Luo
Maosheng Dong
Publikationsdatum: 11.03.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 4/2019
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-019-02878-3

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Retraction Note to: SOX2 oncogenes amplified and operate to activate AKT signalling in gastric cancer and predict immunotherapy responsiveness

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Computer-assisted medical image classification for early diagnosis of oral cancer employing deep learning algorithm

Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma

Prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers

High frequency of H3 K27M mutations in adult midline gliomas

GLRX inhibition enhances the effects of geftinib in EGFR-TKI-resistant NSCLC cells through FoxM1 signaling pathway

Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie